BEIGENE, LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 169.8 USD | +3.00% |
|
+1.22% | -5.36% |
| May. 14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
| May. 09 | Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BEIGENE, LTD. | Bio Therapeutic Drugs | +3.53% | +1.22% | -5.36% | -28.55% | +23.48% | 17.24B |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- BGNE Stock
- Charts BeiGene, Ltd.
- Comparison Chart
